share_log

Leerink Partners Downgrades Progyny to Market Perform, Lowers Price Target to $25

Leerink Partners Downgrades Progyny to Market Perform, Lowers Price Target to $25

Leerink Partners将Progyny评级下调至市场表现,将目标股价下调至25美元。
Benzinga ·  08/07 06:35  · 评级/大行评级

Leerink Partners analyst Michael Cherny downgrades Progyny (NASDAQ:PGNY) from Outperform to Market Perform and lowers the price target from $31 to $25.

Leerink Partners 分析师Michael Cherny将Progyny (纳斯达克:PGNY) 的评级从强力买入调降至持有,将目标价从31美元下调至25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发